| Year |
Citation |
Score |
| 2024 |
Karim F, Riou C, Bernstein M, Jule Z, Lustig G, van Graan S, Keeton RS, Upton JL, Ganga Y, Khan K, Reedoy K, Mazibuko M, Govender K, Thambu K, Ngcobo N, ... ... Karim QA, et al. Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation. Nature Communications. 15: 2360. PMID 38491050 DOI: 10.1038/s41467-024-46673-2 |
0.465 |
|
| 2023 |
Mahomed S, Garrett N, Potloane D, Sikazwe IT, Capparelli E, Harkoo I, Gengiah TN, Zuma NY, Osman F, Mansoor L, Archary D, Myeni N, Radebe P, Samsunder N, Rose ND, ... ... Karim QA, et al. Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. Bmj Open. 13: e076843. PMID 37640457 DOI: 10.1136/bmjopen-2023-076843 |
0.56 |
|
| 2023 |
Collins C, Isbell MT, Karim QA, Sohn AH, Beyrer C, Maleche A. Leveraging the HIV response to strengthen pandemic preparedness. Plos Global Public Health. 3: e0001511. PMID 36963061 DOI: 10.1371/journal.pgph.0001511 |
0.457 |
|
| 2022 |
Karim QA, Archary D, Barré-Sinoussi F, Broliden K, Cabrera C, Chiodi F, Fidler SJ, Gengiah TN, Herrera C, Kharsany ABM, Liebenberg LJP, Mahomed S, Menu E, Moog C, Scarlatti G, et al. Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention. Frontiers in Immunology. 13: 1055042. PMID 36561760 DOI: 10.3389/fimmu.2022.1055042 |
0.541 |
|
| 2022 |
Humphries H, Lewis L, Lamontagne E, Choonara S, Dikgale K, Yakusik A, Massawe D, Mkhize N, Mzungu F, Karim QA. Impact of COVID-19 public health responses on income, food security and health services among key and vulnerable women in South Africa. African Journal of Aids Research : Ajar. 21: 317-329. PMID 36538540 DOI: 10.2989/16085906.2022.2144392 |
0.476 |
|
| 2021 |
Molatlhegi RP, Ngcobo S, Liebenberg LJP, Ngcapu S, Mabhula A, Leslie A, Mchunu N, Zondi MM, Adamson JH, Govender K, Samsunder N, Karim SSA, Karim QA, Passmore JS, Sivro A, et al. Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET-EN), in South African women. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13411. PMID 33641222 DOI: 10.1111/aji.13411 |
0.44 |
|
| 2020 |
Mahomed S, Garrett N, Karim QA, Zuma NY, Capparelli E, Baxter C, Gengiah T, Archary D, Samsunder N, Rose ND, Moore P, Williamson C, Barouch DH, Fast PE, Pozzetto B, et al. Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. Bmj Open. 10: e042247. PMID 33243815 DOI: 10.1136/bmjopen-2020-042247 |
0.445 |
|
| 2020 |
Karim QA, Karim SSA. COVID-19 affects HIV and tuberculosis care. Science. 369: 366-368. PMID 32703860 DOI: 10.1126/Science.Abd1072 |
0.523 |
|
| 2020 |
Karim QA, Havlir D, Phanuphak N. Putting women in the centre of the global HIV response is key to achieving epidemic control Journal of the International Aids Society. 23. PMID 32142213 DOI: 10.1002/Jia2.25473 |
0.572 |
|
| 2019 |
Joyisa N, Moodley D, Nkosi T, Talakgale R, Sebitloane M, Naidoo M, Karim QA. Asymptomatic Bacterial Vaginosis in Pregnancy and Missed Opportunities for Treatment: A Cross-Sectional Observational Study. Infectious Diseases in Obstetrics & Gynecology. 2019: 7808179. PMID 31186607 DOI: 10.1155/2019/7808179 |
0.485 |
|
| 2019 |
Harichund C, Karim QA, Kunene P, Simelane S, Moshabela M. Exploring factors that influence the integration of HIVST with HCT using a qualitative comparative cross-over design in KwaZulu-Natal, South Africa. Global Public Health. 14: 1275-1287. PMID 30829120 DOI: 10.1080/17441692.2019.1587638 |
0.549 |
|
| 2019 |
Harichund C, Kunene P, Simelane S, Karim QA, Moshabela M. Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa Plos One. 14: 1-12. PMID 30794580 DOI: 10.1371/Journal.Pone.0212343 |
0.566 |
|
| 2019 |
Harichund C, Karim QA, Kunene P, Simelane S, Moshabela M. HIV self-testing as part of a differentiated HIV testing approach: exploring urban and rural adult experiences from KwaZulu-Natal, South Africa using a cross-over study design. Bmc Public Health. 19: 1-7. PMID 30634943 DOI: 10.1186/S12889-018-6366-9 |
0.559 |
|
| 2019 |
Harichund C, Moshabela M, Kunene P, Karim QA. Acceptability of HIV self-testing among men and women in KwaZulu-Natal, South Africa. Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 31: 186-192. PMID 30058362 DOI: 10.1080/09540121.2018.1503638 |
0.569 |
|
| 2018 |
Tanko RF, Soares AP, Masson L, Garrett NJ, Samsunder N, Karim QA, Abdool Karim SS, Riou C, Burgers WA. Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression. Clinical Immunology (Orlando, Fla.). PMID 29883708 DOI: 10.1016/J.Clim.2018.06.001 |
0.487 |
|
| 2018 |
Karim QA. Current status of the HIV epidemic & challenges in prevention. The Indian Journal of Medical Research. 146: 673-676. PMID 29664022 DOI: 10.4103/ijmr.IJMR_1912_17 |
0.507 |
|
| 2018 |
McKinnon LR, Liebenberg LJ, Yende-Zuma N, Archary D, Ngcapu S, Sivro A, Nagelkerke N, Garcia Lerma JG, Kashuba AD, Masson L, Mansoor LE, Karim QA, Karim SSA, Passmore JS. Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women. Nature Medicine. PMID 29480895 DOI: 10.1038/Nm.4506 |
0.613 |
|
| 2017 |
Dorward J, Yende-Zuma N, Samsunder N, Karim QA, Drain PK, Garrett N. Clinic-Based Evaluation of A Point-Of-Care Creatinine Assay to Screen for Renal Impairment Amongst Hiv-Positive Patients Receiving Tenofovir Disoproxil Fumarate. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 29271830 DOI: 10.1097/Qai.0000000000001613 |
0.437 |
|
| 2017 |
Rademeyer C, Korber B, Seaman MS, Giorgi EE, Thebus R, Robles A, Sheward DJ, Wagh K, Garrity J, Carey BR, Gao H, Greene KM, Tang H, Bandawe GP, Marais JC, ... ... Karim QA, et al. Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization. Plos Pathogens. 13: e1006641. PMID 28945784 DOI: 10.1371/journal.ppat.1006641 |
0.326 |
|
| 2017 |
Scheepers C, Chowdhury S, Wright WS, Campbell CT, Garrett NJ, Karim QA, Karim SSA, Moore PL, Gildersleeve JC, Morris L. Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses. Aids (London, England). PMID 28926408 DOI: 10.1097/Qad.0000000000001643 |
0.519 |
|
| 2017 |
Garrett N, Norman E, Leask K, Naicker N, Asari V, Majola N, Karim QA, Karim SS. Acceptability of Early Antiretroviral Therapy Among South African Women. Aids and Behavior. PMID 28224322 DOI: 10.1007/S10461-017-1729-2 |
0.402 |
|
| 2017 |
Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Karim QA, Karim SSA, Riou C, Burgers WA. Effect of antiretroviral therapy on the memory and activation profiles of B cells in HIV-infected African women. Journal of Immunology. 198: 1220-1228. PMID 28039305 DOI: 10.4049/Jimmunol.1601560 |
0.462 |
|
| 2016 |
de Oliveira T, Kharsany AB, Gräf T, Cawood C, Khanyile D, Grobler A, Puren A, Madurai S, Baxter C, Karim QA, Karim SS. Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. The Lancet. Hiv. PMID 27914874 DOI: 10.1016/S2352-3018(16)30186-2 |
0.611 |
|
| 2016 |
Chopera DR, Ntale R, Ndabambi N, Garrett N, Gray CM, Matten D, Karim QA, Karim SA, Williamson C. Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women. Aids (London, England). PMID 27755110 DOI: 10.1097/Qad.0000000000001298 |
0.495 |
|
| 2016 |
Selhorst P, Masson L, Ismail SD, Samsunder N, Garrett N, Mansoor LE, Karim QA, Karim SS, Passmore JS, Williamson C. CErvicovaginal inflaMmation Facilitates Acquisition of less infectious HIV variants. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27694480 DOI: 10.1093/Cid/Ciw663 |
0.551 |
|
| 2016 |
Sobieszczyk ME, Werner L, Mlisana K, Naicker N, Feinstein A, Gray CM, Masson L, Passmore JS, Williamson C, Karim QA, Abdool Karim SS, Garrett NJ. Metabolic syndrome after HIV acquisition in South African women. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27391387 DOI: 10.1097/Qai.0000000000001123 |
0.578 |
|
| 2016 |
Kharsany AB, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. The Open Aids Journal. 10: 34-48. PMID 27347270 DOI: 10.2174/1874613601610010034 |
0.639 |
|
| 2016 |
McKinnon LR, Karim QA. Factors Driving the HIV Epidemic in Southern Africa. Current Hiv/Aids Reports. PMID 27137200 DOI: 10.1007/S11904-016-0314-Z |
0.597 |
|
| 2016 |
MacQueen KM, Dlamini S, Perry B, Okumu E, Sortijas S, Singh C, Pillay D, Majors A, Jerome S, Watson S, Karim SA, Karim QA, Mansoor LE. Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa. Aids and Behavior. PMID 26945585 DOI: 10.1007/S10461-016-1339-4 |
0.406 |
|
| 2016 |
Mkhize NN, Durgiah R, Ashley V, Archary D, Garrett NJ, Karim QA, Karim SS, Moore PL, Yates N, Passmore JA, Tomaras GD, Morris L. Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women. Aids (London, England). 30: 1005-14. PMID 26836790 DOI: 10.1097/Qad.0000000000001038 |
0.543 |
|
| 2016 |
Karim QA, Baxter C. The dual burden of gender-based violence and HIV in adolescent girls and young women in South Africa : guest editorial South African Medical Journal. 106: 1151-1153. DOI: 10.7196/Samj.2016.V106I12.12126 |
0.489 |
|
| 2015 |
Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction. Journal of the International Aids Society. 18: 20536. PMID 26700845 DOI: 10.7448/Ias.18.1.20536 |
0.547 |
|
| 2015 |
Kashuba AD, Gengiah TN, Werner L, Yang KH, White NR, Karim QA, Abdool Karim SS. Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 264-9. PMID 26181703 DOI: 10.1097/Qai.0000000000000607 |
0.544 |
|
| 2015 |
Richardson SI, Gray ES, Mkhize NN, Sheward DJ, Lambson BE, Wibmer CK, Masson L, Werner L, Garrett N, Passmore JA, Karim QA, Karim SS, Williamson C, Moore PL, Morris L. South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication. Retrovirology. 12: 54. PMID 26105197 DOI: 10.1186/S12977-015-0183-3 |
0.551 |
|
| 2015 |
Phili R, Karim QA. Acceptability of neonatal circumcision by pregnant women in KwaZulu-Natal, South Africa. Curationis. 38. PMID 26018569 DOI: 10.4102/Curationis.V38I1.1433 |
0.423 |
|
| 2015 |
Ngcapu S, Masson L, Sibeko S, Werner L, McKinnon LR, Mlisana K, Shey M, Samsunder N, Karim SA, Karim QA, Passmore JA. Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. Journal of Reproductive Immunology. 110: 14-21. PMID 25956139 DOI: 10.1016/J.Jri.2015.03.007 |
0.448 |
|
| 2015 |
Dellar RC, Dlamini S, Karim QA. Adolescent girls and young women: key populations for HIV epidemic control. Journal of the International Aids Society. 18: 19408. PMID 25724504 DOI: 10.7448/Ias.18.2.19408 |
0.597 |
|
| 2015 |
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC. Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. The Journal of Infectious Diseases. PMID 25712973 DOI: 10.1093/Infdis/Jiv110 |
0.526 |
|
| 2015 |
Karim SSA, Karim QA, Baxter C. Antibodies for HIV prevention in young women. Current Opinion in Hiv and Aids. 10: 183-189. PMID 25700207 DOI: 10.1097/Coh.0000000000000147 |
0.645 |
|
| 2015 |
Morrison CS, Chen PL, Kwok C, Baeten JM, Brown J, Crook AM, Van Damme L, Delany-Moretlwe S, Francis SC, Friedland BA, Hayes RJ, Heffron R, Kapiga S, Karim QA, Karpoff S, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. Plos Medicine. 12: e1001778. PMID 25612136 DOI: 10.1371/Journal.Pmed.1001778 |
0.58 |
|
| 2015 |
Karim QA, Liebenberg LJ, Leask K, Samsunder N, Kharsany A, Grobler A, McKinnon L, Passmore J, Karim SA. S17.2 Hpv infection, genital inflammation, and hiv risk in the caprisa 004 trial Sexually Transmitted Infections. 91. DOI: 10.1136/Sextrans-2015-052270.76 |
0.43 |
|
| 2015 |
Phili R, Karim QA, Tlou B. Experiences in the implementation of provider-initiated counselling and testing and linkage to HIV services at urban public sector health facilities in KwaZulu-Natal Southern African Journal of Infectious Diseases. 30: 108-112. DOI: 10.1080/23120053.2015.1074433 |
0.519 |
|
| 2014 |
Succop SM, MacQueen KM, van Loggerenberg F, Majola N, Karim QA, Karim SS. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. Aids Care. 26: 1521-5. PMID 25285564 DOI: 10.1080/09540121.2014.938014 |
0.387 |
|
| 2014 |
Kharsany AB, Buthelezi TJ, Frohlich JA, Yende-Zuma N, Samsunder N, Mahlase G, Williamson C, Travers SA, Marais JC, Dellar R, Karim SS, Karim QA. HIV infection in high school students in rural South Africa: role of transmissions among students. Aids Research and Human Retroviruses. 30: 956-65. PMID 25077861 DOI: 10.1089/Aid.2014.0110 |
0.492 |
|
| 2014 |
Montague C, Ngcobo N, Mahlase G, Frohlich J, Pillay C, Yende-Zuma N, Humphries H, Dellar R, Naidoo K, Karim QA. Implementation of adolescent-friendly voluntary medical male circumcision using a school based recruitment program in rural KwaZulu-Natal, South Africa. Plos One. 9: e96468. PMID 24788339 DOI: 10.1371/Journal.Pone.0096468 |
0.527 |
|
| 2014 |
Delva W, Karim QA. The HIV epidemic in Southern Africa - Is an AIDS-free generation possible? Current Hiv\/Aids Reports. 11: 99-108. PMID 24676559 DOI: 10.1007/S11904-014-0205-0 |
0.619 |
|
| 2014 |
MacQueen KM, Weaver MA, van Loggerenberg F, Succop S, Majola N, Taylor D, Karim QA, Karim SA. Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case-control study. Aids and Behavior. 18: 826-32. PMID 24647763 DOI: 10.1007/S10461-014-0753-8 |
0.523 |
|
| 2014 |
Gengiah TN, Upfold M, Naidoo A, Mansoor LE, Feldblum PJ, Karim QA, Karim SSA. Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag study. Aids and Behavior. 18: 833-840. PMID 24643314 DOI: 10.1007/S10461-014-0750-Y |
0.359 |
|
| 2014 |
Mansoor LE, Karim QA, Werner L, Madlala B, Ngcobo N, Cornman DH, Amico KR, Fisher J, Fisher WA, Macqueen KM, Karim SS. Impact of an adherence intervention on the effectiveness of tenofovir gel in the CAPRISA 004 trial. Aids and Behavior. 18: 841-8. PMID 24633717 DOI: 10.1007/S10461-014-0752-9 |
0.408 |
|
| 2014 |
Karim QA, Dellar RC. Inclusion of adolescent girls in HIV prevention research - an imperative for an AIDS-free generation. Journal of the International Aids Society. 17: 19075-19075. PMID 24629847 DOI: 10.7448/Ias.17.1.19075 |
0.575 |
|
| 2014 |
Gengiah TN, Mansoor LE, Upfold M, Naidoo A, Yende-Zuma N, Kashuba ADM, Karim QA, Karim SSA. Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial. Aids and Behavior. 18: 820-825. PMID 24623069 DOI: 10.1007/S10461-014-0749-4 |
0.38 |
|
| 2014 |
Naidoo K, Karim QA, Bhushan A, Naidoo K, Yende-Zuma N, McHunu PK, Frohlich J, Karim F, Upfold M, Kocheleff P, Abdool Karim SS. High rates of tuberculosis in patients accessing HAART in rural South Africa. Journal of Acquired Immune Deficiency Syndromes (1999). 65: 438-46. PMID 24256629 DOI: 10.1097/Qai.0000000000000060 |
0.427 |
|
| 2013 |
Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, ... ... Karim QA, et al. Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial. Plos One. 8: e78818. PMID 24236054 DOI: 10.1371/Journal.Pone.0078818 |
0.543 |
|
| 2013 |
Chopera DR, Mann JK, Mwimanzi P, Omarjee S, Kuang XT, Ndabambi N, Goodier S, Martin E, Naranbhai V, Karim SA, Karim QA, Brumme ZL, Ndung'u T, Williamson C, Brockman MA, et al. No evidence for selection of HIV-1 with enhanced gag-protease or Nef function among breakthrough infections in the CAPRISA 004 tenofovir microbicide trial. Plos One. 8: e71758. PMID 24015191 DOI: 10.1371/Journal.Pone.0071758 |
0.599 |
|
| 2013 |
Baxter C, Yende-Zuma N, Tshabalala P, Karim QA, Karim SSA. Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial. Antiviral Research. 99: 405-408. PMID 23832086 DOI: 10.1016/J.Antiviral.2013.06.019 |
0.393 |
|
| 2013 |
Karim QA, Baxter C, Karim SSA. Topical microbicides--what's new? Journal of Acquired Immune Deficiency Syndromes. 63. PMID 23764627 DOI: 10.1097/Qai.0B013E3182986F80 |
0.565 |
|
| 2013 |
Karim QA. The Global HIV Epidemic: Current Status and Challenges Current Hiv\/Aids Reports. 10: 111-112. PMID 23568544 DOI: 10.1007/S11904-013-0160-1 |
0.57 |
|
| 2013 |
Matthews LT, Sibeko S, Mansoor LE, Yende-Zuma N, Bangsberg DR, Karim QA. Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial. Plos One. 8: e56400. PMID 23472071 DOI: 10.1371/Journal.Pone.0056400 |
0.418 |
|
| 2013 |
Karim QA, Baxter C. Microbicides for the prevention of sexually transmitted HIV infection. Expert Review of Anti-Infective Therapy. 11: 13-23. PMID 23428099 DOI: 10.1586/Eri.12.153 |
0.601 |
|
| 2013 |
Naranbhai V, Altfeld M, Karim SSA, Ndung'u T, Karim QA, Carr WH. Changes in Natural Killer cell activation and function during primary HIV-1 Infection. Plos One. 8: 1-8. PMID 23326405 DOI: 10.1371/Journal.Pone.0053251 |
0.533 |
|
| 2012 |
Naranbhai V, Karim QA, Naidoo K, Yende-Zuma N, Karim SSA. Sustainability of task-shifting for antiretroviral treatment The Lancet. 380: 1907-1908. PMID 23200500 DOI: 10.1016/S0140-6736(12)62110-2 |
0.402 |
|
| 2012 |
Kharsany AB, Mlotshwa M, Frohlich JA, Zuma NY, Samsunder N, Karim SS, Karim QA. HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services. World Health & Population. 13: 43-50. PMID 23089727 DOI: 10.12927/Whp.2012.22966 |
0.533 |
|
| 2012 |
Sokal DC, Karim QA, Sibeko S, Zuma NY, Mansoor LE, Baxter C, Grobler AC, Frohlich JA, Kharsany ABM, Miya N, Mlisana KP, Maarschalk S, Karim SSA. Safety of tenofovir gel, a vaginal microbicide, in South African women: results of the CAPRISA 004 Trial. Antiviral Therapy. 18: 301-310. PMID 22914267 DOI: 10.3851/Imp2311 |
0.379 |
|
| 2012 |
Naranbhai V, Karim SSA, Altfeld M, Samsunder N, Durgiah R, Sibeko S, Karim QA, Carr WH. Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. The Journal of Infectious Diseases. 206: 993-1001. PMID 22829639 DOI: 10.1093/Infdis/Jis465 |
0.562 |
|
| 2012 |
Naranbhai V, Altfeld M, Karim QA, Ndung'u T, Karim SSA, Carr WH. Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial. Aids. 26: 1745-1753. PMID 22781225 DOI: 10.1097/Qad.0B013E328357724F |
0.572 |
|
| 2012 |
Karim SSA, Karim QA. Antiretroviral prophylaxis for HIV prevention reaches a key milestone The Lancet. 379: 2047-2048. PMID 22608193 DOI: 10.1016/S0140-6736(12)60786-7 |
0.565 |
|
| 2012 |
Valley-Omar Z, Sibeko S, Anderson J, Goodier S, Werner L, Arney L, Naranbhai V, Treurnicht F, Abrahams MR, Bandawe G, Swanstrom R, Karim QA, Karim SS, Williamson C. CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. The Journal of Infectious Diseases. 206: 35-40. PMID 22551813 DOI: 10.1093/Infdis/Jis305 |
0.454 |
|
| 2012 |
Gengiah TN, Karim QA. Implementing microbicides in low-income countries Best Practice & Research in Clinical Obstetrics & Gynaecology. 26: 495-501. PMID 22498040 DOI: 10.1016/J.Bpobgyn.2012.02.004 |
0.588 |
|
| 2012 |
Burgers W, Muller T, Kiravu A, Naranbhai V, Sibeko S, Werner L, Karim QA, Karim SA. Infrequent, low magnitude HIV-specific T cell responses in HIV-uninfected participants in the 1% tenofovir microbicide gel trial (CAPRISA004) Retrovirology. 9: 225. DOI: 10.1186/1742-4690-9-S2-P225 |
0.541 |
|
| 2011 |
Karim SSA, Karim QA. Antiretroviral prophylaxis: A defining moment in HIV control The Lancet. 378. PMID 21771566 DOI: 10.1016/S0140-6736(11)61136-7 |
0.596 |
|
| 2011 |
Karim SSA, Kashuba ADM, Werner L, Karim QA. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women The Lancet. 378: 279-281. PMID 21763939 DOI: 10.1016/S0140-6736(11)60878-7 |
0.563 |
|
| 2011 |
Williams BG, Karim SSA, Karim QA, Gouws E. Epidemiological impact of Tenofovir gel on the HIV epidemic in South Africa. Journal of Acquired Immune Deficiency Syndromes. 58: 207-210. PMID 21654503 DOI: 10.1097/Qai.0B013E3182253C19 |
0.559 |
|
| 2011 |
Karim QA, Banegura A, Cahn P, Christie CD, Dintruff R, Distel M, Hankins C, Hellmann N, Katabira E, Lehrman S, Montaner J, Purdon S, Rooney JF, Wood R, Heidari S. Asking the right questions: developing evidence-based strategies for treating HIV in women and children. Bmc Public Health. 11: 388. PMID 21612633 DOI: 10.1186/1471-2458-11-388 |
0.568 |
|
| 2011 |
Venter WDF, Ndung'u T, Karim QA. Case 15-2011: A 19-Year-Old South African Woman with Headache, Fatigue, and Vaginal Discharge The New England Journal of Medicine. 364: 1956-1964. PMID 21591948 DOI: 10.1056/Nejmcpc1100926 |
0.447 |
|
| 2011 |
Heidari S, Eckert MJ, Kippax S, Karim QA, Sow PS, Wainberg MA. Time for gender mainstreaming in editorial policies. Journal of the International Aids Society. 14: 11. PMID 21385405 DOI: 10.1186/1758-2652-14-11 |
0.528 |
|
| 2011 |
Karim QA, Kharsany ABM, Frohlich JA, Baxter C, Yende N, Mansoor LE, Mlisana KP, Maarschalk S, Arulappan N, Grobler AC, Sibeko S, Omar Z, Gengiah TN, Mlotshwa M, Samsunder N, et al. Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial Trials. 12: 67-67. PMID 21385354 DOI: 10.1186/1745-6215-12-67 |
0.604 |
|
| 2011 |
Karim QA, Kharsany ABM, Naidoo K, Yende N, Gengiah T, Omar Z, Arulappan N, Mlisana KP, Luthuli LR, Karim SSA. Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. Contemporary Clinical Trials. 32: 333-338. PMID 21278001 DOI: 10.1016/J.Cct.2011.01.005 |
0.423 |
|
| 2011 |
Naranbhai V, Karim QA, Meyer-Weitz A. Interventions to modify sexual risk behaviours for preventing HIV in homeless youth. Cochrane Database of Systematic Reviews. 1: 1-47. PMID 21249691 DOI: 10.1002/14651858.Cd007501.Pub2 |
0.453 |
|
| 2011 |
Gengiah TN, Gray AL, Naidoo K, Karim QA. Initiating antiretrovirals during tuberculosis treatment: a drug safety review. Expert Opinion On Drug Safety. 10: 559-74. PMID 21204737 DOI: 10.1517/14740338.2011.546783 |
0.37 |
|
| 2011 |
Karim QA, Kharsany ABM, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Karim SSA. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa International Journal of Epidemiology. 40: 922-930. PMID 21047913 DOI: 10.1093/Ije/Dyq176 |
0.614 |
|
| 2011 |
Naidoo K, Naidoo K, Padayatchi N, Karim QA. HIV-Associated Tuberculosis Clinical & Developmental Immunology. 2011: 585919-585919. PMID 20871843 DOI: 10.1155/2011/585919 |
0.56 |
|
| 2010 |
Karim QA, Karim SSA, Baxter C, Friedland GH, Gengiah TN, Gray AL, Grobler AC, Naidoo K, Padayatchi N, El-Sadr W. The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis South African Medical Journal. 100: 808-809. PMID 21414268 DOI: 10.7196/Samj.4621 |
0.518 |
|
| 2010 |
Karim QA, Sibeko S, Baxter C. Preventing HIV Infection in Women: A global Health Imperative Clinical Infectious Diseases. 50. PMID 20397940 DOI: 10.1086/651483 |
0.643 |
|
| 2010 |
Kharsany ABM, Karim QA, Karim SSA. Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa - missed opportunities for early diagnosis of HIV infection. Aids Care-Psychological and Socio-Medical Aspects of Aids\/Hiv. 22: 533-537. PMID 20397075 DOI: 10.1080/09540120903254005 |
0.611 |
|
| 2010 |
Roberts L, Passmore JA, Williamson C, Little F, Bebell LM, Mlisana K, Burgers WA, van Loggerenberg F, Walzl G, Djoba Siawaya JF, Karim QA, Karim SS. Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression. Aids (London, England). 24: 819-31. PMID 20224308 DOI: 10.1097/Qad.0B013E3283367836 |
0.506 |
|
| 2010 |
Karim SSA, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Karim QA. Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy The New England Journal of Medicine. 362: 697-706. PMID 20181971 DOI: 10.1056/Nejmoa0905848 |
0.458 |
|
| 2010 |
Karim SSA, Karim QA. AIDS research must link to local policy Nature. 463: 733-734. PMID 20148015 DOI: 10.1038/463733A |
0.46 |
|
| 2009 |
Gebrekristos HT, Lurie MN, Mthethwa N, Karim QA. Disclosure of HIV status: Experiences of Patients Enrolled in an Integrated TB and HAART Pilot Programme in South Africa. African Journal of Aids Research : Ajar. 8: 1-6. PMID 20411037 DOI: 10.2989/Ajar.2009.8.1.1.714 |
0.583 |
|
| 2009 |
Karim QA. Quarraisha Abdool Karim: investigating HIV/AIDS in South Africa. Interview by Priva Shetty. Lancet (London, England). 374: 871. PMID 19748387 DOI: 10.1016/S0140-6736(09)61615-9 |
0.536 |
|
| 2009 |
Chopra M, Lawn JE, Sanders D, Barron P, Karim SSA, Bradshaw D, Jewkes R, Karim QA, Flisher AJ, Mayosi BM, Tollman SM, Churchyard GJ, Coovadia HM. Achieving the health Millennium Development Goals for South Africa: challenges and priorities The Lancet. 374: 1023-1031. PMID 19709737 DOI: 10.1016/S0140-6736(09)61122-3 |
0.39 |
|
| 2009 |
Karim SSA, Churchyard GJ, Karim QA, Lawn SD. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. The Lancet. 374: 921-933. PMID 19709731 DOI: 10.1016/S0140-6736(09)60916-8 |
0.594 |
|
| 2009 |
Vermund SH, Allen KL, Karim QA. HIV-prevention science at a crossroads: Advances in reducing sexual risk Current Opinion in Hiv and Aids. 4: 266-273. PMID 19532063 DOI: 10.1097/Coh.0B013E32832C91Dd |
0.59 |
|
| 2009 |
Mastro TD, Karim QA. The power of HIV/AIDS epidemiology. Current Opinion in Hiv and Aids. 4: 237-239. PMID 19532058 DOI: 10.1097/Coh.0B013E32832C92Ac |
0.553 |
|
| 2009 |
McCormack S, Taylor D, Richardson B, Darbyshire J, Sattentau Q, Karim QA, Karim SS, Kharsany A, Lacey C, Nunn A, Weber J. Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al. Aids Research and Human Retroviruses. 25: 373; author reply 37. PMID 19292591 DOI: 10.1089/Aid.2008.0229 |
0.475 |
|
| 2009 |
Karim QA, Hassanally L. HIV epidemic types and customized prevention responses. Focus (San Francisco, Calif.). 23: 1-4. PMID 19062778 |
0.479 |
|
| 2008 |
Bebell LM, Passmore JA, Williamson C, Mlisana K, Iriogbe I, van Loggerenberg F, Karim QA, Karim SA. Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. The Journal of Infectious Diseases. 198: 710-4. PMID 18643751 DOI: 10.1086/590503 |
0.54 |
|
| 2007 |
Karim QA. Prevention of HIV by male circumcision. Bmj. 335: 4-5. PMID 17615186 DOI: 10.1136/Bmj.39245.491169.Be |
0.481 |
|
| 2007 |
Karim SSA, Karim QA, Gouws E, Baxter C. Global Epidemiology of HIV-AIDS Infectious Disease Clinics of North America. 21: 1-17. PMID 17502227 DOI: 10.1016/J.Idc.2007.01.010 |
0.602 |
|
| 2007 |
Gaym A, Mashego M, Kharsany AB, Walldorf J, Frohlich J, Karim QA. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde. 97: 120-3. PMID 17404673 |
0.511 |
|
| 2007 |
MacQueen KM, Karim QA. Practice brief: adolescents and HIV clinical trials: ethics, culture, and context. The Journal of the Association of Nurses in Aids Care : Janac. 18: 78-82. PMID 17403499 DOI: 10.1016/J.Jana.2007.01.002 |
0.619 |
|
| 2007 |
Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia HM, Giddy J. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. Bmc Pediatrics. 7: 13. PMID 17367540 DOI: 10.1186/1471-2431-7-13 |
0.466 |
|
| 2007 |
Karim SSA, Mlisana KP, Kharsany ABM, Williamson C, Baxter C, Karim QA. Utilizing nucleic acid amplification to identify acute HIV infection. Aids. 21: 653-655. PMID 17314532 DOI: 10.1097/Qad.0B013E3280327923 |
0.538 |
|
| 2007 |
Gaym A, Mashego M, Kharsany ABM, Walldorf J, Frohlich JA, Karim QA. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations. South African Medical Journal. 97: 120-123. DOI: 10.7196/Samj.462 |
0.612 |
|
| 2007 |
Karim QA. The HIV Pandemic: Local and Global Implications Hiv Clinical Trials. 8: 356-356. DOI: 10.1310/Hct0805-356 |
0.563 |
|
| 2006 |
Singh JA, Karim SSA, Karim QA, Mlisana KP, Williamson C, Gray CM, Govender M, Gray AL. Enrolling adolescents in research on HIV and other sensitive Issues: lessons from South Africa. Plos Medicine. 3. PMID 16608384 DOI: 10.1371/Journal.Pmed.0030180 |
0.563 |
|
| 2006 |
Naranbhai V, Karim QA. HIV prevention and treatment research in sub-Saharan Africa : where are the adolescents? Aids. 20: 1090-1091. PMID 16603874 DOI: 10.1097/01.Aids.0000222094.82529.20 |
0.603 |
|
| 2006 |
Kharsany ABM, Connolly C, Olowolagba A, Karim SSA, Karim QA. Increasing burden of pulmonary tuberculosis in young women South African Medical Journal. 96: 524-525. DOI: 10.7196/Samj.1138 |
0.418 |
|
| 2006 |
Kharsany ABM, Mashego M, Mdlotshwa M, Frohlich J, Karim QA. Direct questioning of genital symptoms: increasing opportunities for identifying and treating sexually transmitted infections in primary health-care settings. African Journal of Reproductive Health. 10: 105-114. DOI: 10.2307/30032463 |
0.364 |
|
| 2005 |
Gebrekristos HT, Mlisana KP, Karim QA. Patients' readiness to start highly active antiretroviral treatment for HIV. Bmj (Clinical Research Ed.). 331: 772-5. PMID 16195299 DOI: 10.1136/Bmj.331.7519.772 |
0.494 |
|
| 2005 |
Gebrekristos HT, Lurie MN, Mthethwa N, Karim QA. Knowledge and acceptability of HAART among TB patients in Durban, South Africa. Aids Care. 17: 767-72. PMID 16036263 DOI: 10.1080/09540120412331336661 |
0.606 |
|
| 2005 |
Woodsong C, Karim QA. A model designed to enhance informed consent: experiences from the HIV prevention trials network. American Journal of Public Health. 95: 412-9. PMID 15727968 DOI: 10.2105/AJPH.2004.041624 |
0.44 |
|
| 2005 |
Strode AE, Rooyen HV, Heywood M, Karim QA. Scaling up HIV testing in resource-constrained settings: Debates on the role of VCT and Routine ‘Opt-in or Opt-out’ HIV Testing Southern African Journal of Hiv Medicine. 6: 45-48. DOI: 10.4102/Sajhivmed.V6I3.582 |
0.6 |
|
| 2004 |
MacQueen KM, Shapiro K, Karim QA, Sugarman J. Ethical challenges in international HIV prevention research. Accountability in Research. 11: 49-61. PMID 15341046 DOI: 10.1080/08989620490280230 |
0.51 |
|
| 2004 |
Jack C, Lalloo UG, Karim QA, Karim SSA, El-Sadr W, Cassol S, Friedland GH. A pilot study of once-daily antiretroviral therapy integrated with tuberculosis directly observed therapy in a resource-limited setting. Journal of Acquired Immune Deficiency Syndromes. 36: 929-934. PMID 15220699 DOI: 10.1097/00126334-200408010-00006 |
0.453 |
|
| 2004 |
Friedland G, Karim SA, Karim QA, Lalloo U, Jack C, Gandhi N, Sadr WE. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. Clinical Infectious Diseases. 38: 421-428. PMID 15156433 DOI: 10.1086/421407 |
0.59 |
|
| 2004 |
Karim QA. HIV treatment in South Africa: overcoming impediments to get started. The Lancet. 363: 1394. PMID 15112695 DOI: 10.1016/S0140-6736(04)16055-8 |
0.584 |
|
| 2004 |
Karim SSA, Karim QA, Friedland G, Lalloo U, Sadr WME. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. Aids. 18: 975-979. PMID 15096799 DOI: 10.1097/00002030-200404300-00004 |
0.561 |
|
| 2003 |
Karim SSA, Karim QA, Baxter C. Antiretroviral therapy: challenges and options in South Africa The Lancet. 362: 1499-1499. PMID 14602450 DOI: 10.1016/S0140-6736(03)14700-9 |
0.307 |
|
| 2003 |
MacQueen KM, Karim QA, Sugarman J. Ethics guidance for HIV prevention trials. Bmj (Clinical Research Ed.). 327: 340. PMID 12907494 DOI: 10.1136/Bmj.327.7410.340 |
0.567 |
|
| 2001 |
Rustomjee R, Karim QA. Microbicide research and development--where to? Hiv Clinical Trials. 2: 185-192. PMID 11590526 DOI: 10.1310/5Uvd-B5Fl-Rqaf-Gdpn |
0.766 |
|
| Show low-probability matches. |